Dolutegravir

Dolutegravir · Second-generation integrase strand transfer inhibitor

In combination with other antiretrovirals for HIV-1 in adults and children

50mg tablets Once daily oral Insurance Category B

Therapeutic Areas

HIV & Infectious

Marketed Products

Dolutegravir

Modality

Dolutegravir

Core Products

Bictegravir/FTC/TAF · Single-tablet triple regimen

Emtricitabine · Nucleoside reverse transcriptase inhibitor

Raltegravir · First-generation integrase inhibitor

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide